Qrono: Qrono and Inflammatory Response Research Announce Collaboration to Develop LongActing Therapeutics for Acute Radiation Syndrome

The QronoIRR collaboration will further the development of available medical countermeasures for acute radiation syndromePITTSBURGH PA PRWEB August 09 2016 Qrono Inc. a specialty pharmaceutical company focused on longacting injectables LAIs and Inflammato...